how long has semaglutide been fda approved U.S. | The FDA a new higher dose (7.2 mg) of Wegovy ( semaglutide) injection, Wegovy HD, for weight loss and long-term weight FDA Approves Oral Semaglutide for

In 2022 alone, nine million Americans were prescribed Ozempic, and that could rise to 24 million in the next decade, according to analysis by Morgan Stanley

The cardiovascular protective mechanisms of GLP-1 receptor agonists are thought to include: Improved glycaemic control , reducing endothelial dysfunction associated with hyperglycaemia Weight reduction , decreasing metabolic stress and inflammation Blood pressure lowering , potentially through effects on fluid balance and vascular function Favourable lipid profile changes , including modest reductions in LDL cholesterol and triglycerides Anti-inflammatory effects , reducing systemic markers of inflammation such as C-reactive protein [20] [21] Regulatory bodies including the MHRA and EMA have not identified thrombotic events as a specific safety concern with GLP-1 receptor agonists

GLP-1 RAs are very effective at lowering blood sugar levels

Online healthcare platforms will deliver prescriptions to a local pharmacy